Search Within

WALDENSTROM MACROGLOBULINEMIA

Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 1
Page: 15-34
Authors: Tadeusz Robak, Agnieszka Wierzbowska and Ewa Robak

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 3
Page: 254-284
Authors: B. C. Potts, M. X. Albitar, K. C. Anderson, S. Baritaki, C. Berkers, B. Bonavida, J. Chandra, D. Chauhan, J. C. Cusack, W. Fenical, I. M. Ghobrial, M. Groll, P. R. Jensen, K. S. Lam, G. K. Lloyd, W. McBride, D. J. McConkey, C. P. Miller, S. T.C. Neuteboom, Y. Oki, H. Ovaa, F. Pajonk, P. G. Richardson, A. M. Roccaro, C. M. Sloss, M. A. Spear, E. Valashi, A. Younes and M. A. Palladino

Anti-Angiogenic Therapies in the Treatment of Waldenstrom's Macroglobulinemia

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1025-1029
Authors: A. Sacco, I. M. Ghobrial and A. M. Roccaro